Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that stimulates the proliferation, maturation, and functional activity of myeloid cells in peripheral blood and bone marrow. Expression of GM-CSF is tightly regulated and is limited to cells stimulated directly (T cells, macrophages) or indirectly (fibroblasts, endothelial cells) by immune challenge. Several studies of the transcriptional control of GM-CSF expression have elucidated a region of the GM-CSF promoter that mediates positive regulatory activity in a number of cell types. This region contains a direct repeat of the sequence CATTA/T that extends from nucleotides -37 to -48 upstream of the start of RANULOCYTE-MACROPHAGE colony-stimulating factor (GM-CSF) is a multi-lineage hematopoietic growth factor capable of stimulating the proliferation and maturation of immature myeloid cells, as well as enhancing the functional activity of mature effector cells.' Although significant accumulation of GM-CSF mRNA has not been detected in unstimulated cells, a number of tissues have been shown to be capable of GM-CSF expression in response to a variety of stimuli.'"' These include antigen or mitogen- .'' Constitutive transcription of GM-CSF has been detected in fibroblasts and endothelial cells suggesting that much of the regulation of GM-CSF expression in these cells is posttranscriptional.",'* However, examination of GM-CSF expression in unstimulated T lymphocytes failed to detect constitutive transcription, suggesting that in these cells transcriptional mechanisms are responsible for regulating production of GM-CSF." A number of studies have used the reporter gene approach to identify elements within the GM-CSF promoter that mediate mitogen-inducible transcription.'3,'4"7 We have combined this approach with analysis of binding of nuclear factors to the human GM-CSF promoter and have described an element centered upon a direct repeat of the sequence CATTAR that is critical for inducible GM-CSF promoter activity in T-cell lines and in primary T lymphocytes.I6 This work has recently been confirmed by Wang et all8 in the human Jurkat T-cell line and by Miyatake et a1 using murine GM-CSF promoter sequences.I7 In the current study, we have identified several nuclear factors that specifically interact with this critical element.
RANULOCYTE-MACROPHAGE colony-stimulating
factor (GM-CSF) is a multi-lineage hematopoietic growth factor capable of stimulating the proliferation and maturation of immature myeloid cells, as well as enhancing the functional activity of mature effector cells.' Although significant accumulation of GM-CSF mRNA has not been detected in unstimulated cells, a number of tissues have been shown to be capable of GM-CSF expression in response to a variety of stimuli.'"' These include antigen or mitogenstimulated T lymphocyte^,^.^ tumor necrosis factor (TNF)
or interleukin-l (IL-1)-stimulated fibroblast and endothelial cell population^,'.^.^ lipopolysaccharide-activated B-cell lines7 and macrophages,' and mast cells stimulated through an FceRI receptor-associated pathway.'.'' Constitutive transcription of GM-CSF has been detected in fibroblasts and endothelial cells suggesting that much of the regulation of GM-CSF expression in these cells is posttranscriptional.",'* However, examination of GM-CSF expression in unstimulated T lymphocytes failed to detect constitutive transcription, suggesting that in these cells transcriptional mechanisms are responsible for regulating production of GM-CSF." A number of studies have used the reporter gene approach to identify elements within the GM-CSF promoter that mediate mitogen-inducible transcription.'3,'4"7 We have combined this approach with analysis of binding of nuclear factors to the human GM-CSF promoter and have described an element centered upon a direct repeat of the sequence CATTAR that is critical for inducible GM-CSF promoter activity in T-cell lines and in primary T lymphocytes.I6 This work has recently been confirmed by Wang et all8 in the human Jurkat T-cell line and by Miyatake et a1 using murine GM-CSF promoter sequences.I7 In the current study, we have identified several nuclear factors that specifically interact with this critical element.
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MATERIALS AND METHODS
DNase I footprint analysis. DNase I footprinting probes were prepared by subcloning Ss?-I fragments of previously described plasmids +pCSFpl, +CSFplACATT-1-2, +pCSFplACATT-l, and + C S F P~A C A T T -~'~ into the SstI site of Bluescript (pM13+KS). These constructs were digested with BamHI, treated with calf intestinal alkaline phosphatase, and end-labeled using y3*P-dATP and T4 polynucleotide kinase. A 212-bp footprinting probe was isolated by digestion with SauI and gel purification using a 10% polyacrylamide gel. The probe was visualized by a l-minute exposure to Kodak XOMat film (Kodak, Rochester, NY), excised from the gel, and eluted by overnight mixing in elution buffer (0.5 mmol/L ammonium acetate, 1 mmol/L EDTA). The probe was precipitated in cold ethanol and resuspended in water to a concentration of 1 to 2 ng/pL.
Preparation of nuclear extracts (modified Dignam procedure) and details of the DNase I footprint analyses are as previously published."
Electrophoretic mobility shi3 and ultraviolet cross-linking analysis. Probes for electrophoretic mobility shift assay (EMSA) were prepared by synthesis of complementary single stranded oligonucleotides using an Applied Biosystems Inc Synthesizer (Applied Biosystems Inc, Foster City, CA). The sequences of the oligonucleotides are shown in Fig 1. Complementary strands were annealed and endlabeled using y'*P-dATP and T4 polynucleotide kinase. Labeled probe was purified from free nucleotide by use of Push Columns (Stratagene, La Jolla, CA). To enhance the efficiency of ultraviolet cross-linking, thymidine residues on both strands of the CATTA/T region were substituted with bromodeoxyuridine during synthesis. These substitutions had no effect on the gel shift pattern, but considerably improved cross-linking efficiency (data not shown). EMSA were performed by incubation of I ng "P-labeled double stranded oligonucleotide probe with 2 to 5 pg nuclear extract in the presence of 1 pg poly(dIdC):(dIdC) and 5 pg bovine serum albumin in 20 pL gel shift buffer (20 mmol/L tris-HCI pH 7.4, 50 mmol/L NaCI, 1 mmol/L EDTA, 10 mmol/L MgCI,, 0.5 mmol/L dithiothreitol, 25% vol/vol glycerol) for 30 minutes on ice.
In experiments following the initial competitor titration (Fig 2) , 500 to 600 ng of mutant competitor ACATT-I,-2 ( Fig  I) was also included in the incubation mix. This oligonucleotide contains a repeat of sequences from -56 to -35 of' the inactive -626ACATT-1-2 construct and was included to reduce nonspecific binding. After incubation, the samples were loaded onto B 6% polyacrylamide gel and run at a constant current of 12 mA in 0.4 X TBE. Gel shift analysis gels were dried and placed on film at -70°C.
For ultraviolet (UV) cross-linking studies, EMSA gels were wrapped in SaranWrap (Dow, Indianapolis, IN) and irradiated at 300 nm for 5 to 10 minutes using a Hoefer (San Francisco, CA) 'Mighty Bright' UV transilluminator. Shifted bands were visualized by exposure on Kodak X-OMat film for 3 to 18 hours, excised, and eluted from the acrylamide by mixing for 6 to 18 hours in sodium dodecyl sulfate (SDS) sample loading buffer (125 mmol/L tris-HCI pH 6.8, 6. I % wt/vol SDS, 20% vol/vol glycerol). Cross-linked species were resolved on a 10% SDS-polyacrylamide gel alongside I4C-labeled protein size standards. Gels were fixed in 30% methanol: 10% acetic acid, dried, and exposed on Kodak X-OMat film. Scanning densitometry was performed using an OneScanner (Apple Computer Inc, Cupertino, CA) with "Image" v1.47 analysis software (NIH, Bethesda, MD).
For immunoblotting, specific EMSA bands were eluted as for UV cross-linking, electrophoresed over 7.5% acrylamide SDS-Trisglycine gels, and electroblotted onto Hybond-ECL nitrocellulose (Amersham, Arlington Heights, IL). Membranes were blocked with Tris-buffered saline containing 0. I Q/O Tween-20 (Sigma, St Louis, MO) and 4% nonfat dried milk. Immune complexes were visualized with biotinylated goat-anti-rabbit immunoglobulin Ig) antibody and streptavidin-horseradish peroxidase conjugate and ECL chemiluminescent detection reagents (Amersham). probe, the region of protection from DNase I digestion is from nucleotides -64 to -33-a region centered on the critical CATT"/T repeat (nucleotides -48 to -37, Fig 3A,  lanes 1 and 2) . This pattern is essentially the same as that which we previously published using extract from unstimulated MLA 1 4 4 cells and from S-LB-1 cells." Mutation of the CATT"/T repeats by nucleotide substitution (probe ACATT-1-2) significantly reduced protection over a 10 bp region extending from -48 to -39 (Fig 3A, lanes 3 and 4) . Mutating only two nucleotides in the CATT-2 motif (probe ACATT-2) gave an identical result (Fig 3A. lanes S and 6) . By contrast, mutation of three nucleotides in the downstream CATT"/T motif (probe ACATT-I) showed a different pattern with loss of protection over nucleotides -42 to -44 (Fig 3A. lanes 7 and 8) . All three mutant promoters are inactive in transient transfection assays even in the context of 626bp of upstream sequence.'" Our previous studies'".'" have demonstrated that the activity of GM-CSF promoter constructs in stimulated T cells and T-cell lines is similar to their activity in the human Tcell leukemia virus (HTLV-I)-infected T-cell line S-LB-I . Therefore we also performed DNase I footprint analysis using nuclear extracts prepared from S-LB-I cells. This protection extended from nucleotide -64 to -24 ( Fig 3B, lanes  I and 2) . As with the T-cell extract, the strongest protection was observed directly over the CATT"/T repeat. However, the S-LR-1 nuclear extract protected additional sequences located downstream of the CATT"/T repeat, although the TATA homology was incompletely protected. Mutation of both CATT"/T repeats (probe ACATT-1-2) resulted in the same change in the DNase I footprint pattern as was seen with the PHA-stimulated primary T-cell extract (loss of protection of nucleotides -48 to -39, Fig 3B, lanes 3 and  4) . A similar DNase I footprint was also seen using probe ACATT-2 ( Fig 3B, lanes S and 6) . A distinct footprint pattern was seen using probe ACATT-I with loss of protection over a region extending from -36 to -38 (Fig 3B, lanes 7  and 8) . This differs from that seen with the T-lymphocyte extract where loss of protection was seen over nucleotides -42 to -44. This observation may reflect differences in the relative amounts of different binding activities in these extracts.
RESULTS
DNase
EMSA and dtrnviolet cross-linking nnnlysis. We next performed EMSA and UV cross-linking analysis to examine the number and size of the proteins involved in these DNA:protein interactions. We examined the CATT"/T-repeat binding proteins present in nuclear extracts prepared from unstimulated and stimulated MLA 1 4 4 cells (Fig 2A  and B) and from S-LB-I cells (Fig 2C) . This analysis was performed using a probe containing the critical CATT"/T repeat (24merWT, nucleotides -S2 to -M), that has previously been shown to bind nuclear factors present in HTLVuninfected cells.'" EMSA analysis showed that in the absence of competitor oligonucleotide, several shifted bands were evident (Fig 2A) . All bands were titrated out by addition of 500-fold molar excess of unlabeled wild-type competitor. However, a mutant competitor containing the ACATT-1-2 sequence left three specific bands, labeled A. B, and C, with each extract (Fig 2) . No reproducible difference in the pattern of EMSA bands was seen between stimulated and unstimu- lated cells. The ACATT-1-2 competitor was included in all subsequent gel mobility shift reactions.
We then employed UV cross-linking to induce formation of covalent linkages between DNA and bound proteins, separating the various DNA binding proteins by denaturing SDSpolyacrylamide gel electrophoresis (SDS-PAGE). The results for each specific EMSA complex (A, B, and C) are presented in Fig 4A. Thus, EMSA band A resolved into three complexes, labeled I, 11, and 111, each of which was present in all three extracts. A fourth, weaker complex (Complex IV) was also seen with all extracts, but was considerably stronger (> 15-fold by densitometry) with extracts prepared from stimulated MLA 144 cells and S-LB-1 cells (Fig 4A, EMSA Band A, and Fig 4B, lanes 2 and 4) .
Another reproducible difference between resting and stimulated MLA 1 4 4 cells was that, although the intensity of EMSA band A was the same for both extracts, the intensity of all of the cross-linked species derived from EMSA band A using stimulated MLA 1 4 4 cells was considerably greater than that from unstimulated cells (Fig 4B, compare lanes 1  and 2) . In Fig 4A, EMSA band A, different exposure times were used to match the lanes for band intensity to show the number of species present, while Fig 4B, lanes 1 and 2, shows equal exposure of cross-linked species from EMSA band A using equal amounts of nuclear extract. This increased intensity was observed using three different preparations of stimulated and unstimulated extract. By scanning densitometry, this difference in the intensity of cross-linked bands was of the order of fivefold to eightfold. However, even when the exposures were matched for intensity of other complexes, Complex IV was still greater than IO-fold stronger in extracts from stimulated cells (Fig 4B, lanes 3  and 4) . These lanes used electroelution of the cross-linked band from the EMSA gel, a modification that resulted in improved resolution of Complexes Ill and IV. This exposure also demonstrated that Complex Ill is separable into two sub-species, although this probably reflects differential 
9 . cross-linking events such as formation of DNA:DNA:protein adducts (Fig 4) . EMSA band B also resolved into multiple species, with the same mobility as complexes 11, 111, and IV. Again Complex IV was not well resolved from Complex 111, but it was reproducible and was not seen with extract from unstimulated MLA 1 4 4 cells. By contrast, EMSA band C resolved into a single complex of the same mobility as Complex 111.
Masuda et al have presented data that suggest the NFATp/AP-I complex binds to the CATT repeat region of the GM-CSF promoter. Because of the similarity in size between Complex I and the NF-ATp protein, we examined the ability of an oligonucleotide containing the IL-2 NF-AT binding site (Fig S) to compete for binding for these specific EMSA complexes. No competition was seen for any band even at a 500-fold molar excess of NF-AT oligonucleotide (data not shown). We also employed Western analysis using antibodies directed to both c~f i s and c-jun to determine if any of the cross-linked species could be attributed to these proteins. In this analysis EMSA complexes were eluted without crosslinking and separated by SDS-PAGE before blotting and detection with the antibodies. While both proteins were easily detected in crude S-LB-1 nuclear extract and in a specific EMSA complex using a labeled AP-I oligonucleotide, they were not observed in any specific EMSA complex using labeled GM-CSF promoter sequence (data not shown).
EMSA and UV cross-linking analysis with mutant probes.
We have previously demonstrated that both copies of the repeat of the CATTAlT motif are required for GM-CSF promoter activity.I6 To investigate if identical factors bind to each motif, we performed EMSA/UV cross-linking analysis using probes containing one wild type and one mutant copy of each of the CATTA/T motifs. The pattern of gel mobility shift bands and the cross-linked species are shown in Fig  6A. Each EMSA probe contains the same nucleotide substitutions used in footprint probes ACATT-I and ACATT-2 1 t o 3). B (lanes 4 t o 6 ). and C (lanes 7 t o 9) from unstimulated MLA 1 4 4 (lanes 1, 4, and 7) , PHA/TPA-stimulated MLA l 4 4 (lanes 2, 5, and 81, and SLB-I (lanes 3,6, and 9) cell nuclear extracts were cross-linked in situ, excised, eluted, and resolved by SDS-PAGE. (see Fig 3) and shows two gel shift complexes, one apparently held in common between the two probes (Complex E) and another unique to each (Complexes D and F). UV crosslinking analysis shows that both E EMSA bands contain two cross-linked complexes of similar mobility to Complex 111 seen with wild-type probe. The upper band that is unique to probe 24merACATT-2 (Complex D) contains a single crosslinked species (Fig 6B, lane 3) that is apparently identical to Complex I seen with wild type probe. Band F, which is seen with probe 24merACATT-l but not with probe 24mer-ACATT-2, contains three DNA:protein complexes (11, 111, and IV) in a pattern that is identical to that seen with EMSA band B.
DISCUSSION
A number of proteins capable of binding to the GM-CSF promoter have been described. These include NFKB," NFGMa and NF-GMb,*' NF-GM2,' the Ets family member Elf-I and the NF-ATp/AP-1 complex. The importance of these binding events to the mitogen inducibility of the GM-CSF promoter is unclear, because, with the exception of Elf-l and NF-AT, the binding sites of these factors lie upstream of sequences critical for promoter activity.I6 In this study we have examined binding of proteins to both wildtype and mutant GM-CSF promoter sequences. The crosslinked species seen in Complex D (using the wild-type oligonucleotide) is consistent in both size and DNA binding specificity with Elf-l. Wang et al recently demonstrated that an antibody to Elf-l abolishes a specific and inducible GM-CSF promoter EMSA complexIx and Nimer et al have demonstrated that recombinant Elf-l can bind to these GM-CSF promoter sequences (unpublished data). In contrast, although certain of the cross-linked species are consistent in size with the NF-ATp/AP-I complex, an oligonucleotide containing the complete NF-AT binding site from the IL-2 promoter showed no ability to bind any of the proteins that recognize the GM-CSF promoter. Further, we were also unable to detect c-fis or c-jun in any specific EMSA complex with GM-CSF promoter sequences. In addition, this region of the promoter has very limited homology with the NF-AT binding site and the region with the greatest homology (Fig S) GGTCACCATTAATCATTTCCTCTGTG GM-CSF Promoter CCAGTGGTAATTAGTAAAGGAGACAC that, unless Elf-I is a part of the NF-AT complex, these two factors cannot simultaneously bind to the promoter, and that they cannot both be involved in GM-CSF activation. Wang et al have proposed a model in which GM-CSF transcription is mediated by the combined effects of Elf-l and c-fos and junB.IX While our data are consistent with a role for Elf-l, the observation that c:fos was undetectable in any specific EMSA complex, though clearly evident in crude extract, suggests that alternative factors are involved. In this regard, it is noteworthy that while an Elf-l antibody completely abolished the EMSA band observed by Wang et al. '5 This suggests that, rather than mutating a repressor element, these mutations might have created a novel and artefactual AP-I binding site in this region. Thus, the increase may be due to spurious recruitment of an activator, rather than loss of a repressor. Analysis of additional mutations through the CATT-2 region indicate that, like the Elf-l motif, these sequences are essential for mitogen inducibility. Therefore, though the nature of the proteins which interact with this region of the GM-CSF promoter remains unclear, the data are consistent with a model in which these factors 
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Gel mobility shift Using probes For personal use only. on October 3, 2017. by guest www.bloodjournal.org From mediate mitogen inducibility. Only the proteins responsible for Complex IV were mitogen-inducible, suggesting that they play a critical role in regulating GM-CSF expression. As with the models proposed by others, our data suggest a mechanism in which induction of GM-CSF transcription requires two binding events; as proposed by Wang et al, we suggest that one event is binding of Elf-l or an Elf-l-like factor to sequences overlapping CATT-I (Fig 5) . However, we propose that the other event requires the synthesis or activation of the species responsible for Complex IV, which binds to CATT-2.
